Assessment of Abraxane in Metastatic Breast Cancer in a Real-life Setting

Trial Profile

Assessment of Abraxane in Metastatic Breast Cancer in a Real-life Setting

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Advanced breast cancer
  • Focus Adverse reactions
  • Sponsors Celgene Corporation
  • Most Recent Events

    • 22 Feb 2017 Status changed from recruiting to completed.
    • 11 Oct 2016 Results (n=203) assessing safety and efficacy presented at the 41st European Society for Medical Oncology Congress.
    • 23 Sep 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top